Follow-Up of Patients With Complete Remission of Locally Advanced Basal Cell Carcinoma After Vismodegib Discontinuation: A Multicenter French Study of 116 PatientsF. Herms, Nicole Basset‐Séguin, Jérôme Lambert et al.|Journal of Clinical Oncology|2019Cited by 69
Regulation of CD4+NKG2D+ Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15Rα and NKG2D TriggeringAna I. Romero, Laurence Zitvogel, Sophie Caillat‐Zucman et al.|Cancer Research|2013Cited by 40
Severe cutaneous adverse reaction associated with vemurafenib: <scp>DRESS</scp>,<scp> AGEP</scp> or overlap reaction?A. Gey, Thomas Jouary, B. Milpied et al.|Journal of the European Academy of Dermatology and Venereology|2014Cited by 30
Follow-up of patients with complete remission of locally advanced basal cell carcinoma treated with vismodegib after treatment discontinuation: A retrospective multicentric French study.F. Herms, Nicole Basset‐Séguin, Luc Haudebourg et al.|Journal of Clinical Oncology|2017Cited by 7